Medicina Interna HUMT

June 2026 Continuum issue on Cerebrovascular Disease. Here are the 15 highest-yield clinical updates that will likely change how many of us practice stroke medicine. 🧵 1️⃣ Prevention is becoming more individualized. The PREVENT risk calculator is replacing older risk paradigms by incorporating cardiovascular, kidney and metabolic disease burden. Stroke prevention is increasingly being framed as brain-health preservation, not simply event prevention. 2️⃣ Not every AF detected after stroke is the same AF. Longer monitoring finds more atrial fibrillation. But the issue raises an important question: Does every brief episode detected after stroke carry the same embolic significance as established clinical AF? Detection ≠ causation. 3️⃣ Silent brain infarcts are common. But finding an incidental infarct on MRI does NOT automatically mean aspirin. Risk-factor modification remains the primary intervention in many of these patients. 4️⃣ PFO closure is becoming more nuanced. The conversation is moving beyond: "PFO present = close it." Instead: Was the stroke truly PFO-related? Large shunt. Atrial septal aneurysm. High RoPE/PASCAL profile. Mechanism matters. 5️⃣ Large-core infarction is no longer an automatic EVT exclusion. Probably the single biggest treatment expansion in recent years. Patients previously considered "too large to treat" may still derive meaningful benefit from thrombectomy when appropriately selected. Many stroke pathways need updating. 6️⃣ Basilar thrombectomy has become much harder to ignore. The evidence base is substantially stronger than it was a few years ago. A severe basilar occlusion patient presenting late should not automatically be considered outside treatment opportunity. 7️⃣ MeVO thrombectomy remains an evidence frontier. Many centers are increasingly treating medium-vessel occlusions. The field is moving fast. But the issue appropriately reminds us that evidence is still evolving. Avoid turning enthusiasm into dogma. 8️⃣ Pregnancy stroke management is becoming more aggressive. A key message: Do not delay necessary imaging. CT. CTA. Mechanical thrombectomy. Maternal neurological rescue remains the priority. Many clinicians are still more conservative than current evidence supports. 9️⃣ CVT management remains surprisingly simple. Even when venous hemorrhage is present: Anticoagulation remains standard treatment. Many trainees still find this counterintuitive. 🔟 Young stroke is increasingly becoming a different disease than older stroke. Dissection. Moyamoya. Congenital heart disease. PFO. CVT. Sickle cell disease. Yet after age 35, conventional vascular risk factors begin dominating much more than many clinicians realize. 1️⃣1️⃣ Women still experience treatment disparities. One uncomfortable message from the issue: Women benefit from thrombolysis and thrombectomy similarly to men. Yet treatment rates remain unequal. Every stroke center should know its own numbers. 1️⃣2️⃣ Intracerebral hemorrhage recovery is often underestimated. The issue repeatedly cautions against early nihilism. Meaningful recovery may continue for months. The first week does not always predict the final outcome. 1️⃣3️⃣ MRI markers are increasingly driving ICH decisions. Microbleeds. Cortical superficial siderosis. CAA markers. These findings increasingly influence future antithrombotic decisions. MRI is becoming a prognostic tool, not merely a diagnostic one. 1️⃣4️⃣ Symptomatic intracranial stenosis remains a medical disease first. Despite advances in intervention: Aggressive medical therapy + 90-day DAPT remains the foundation. The issue strongly reinforces lessons learned after SAMMPRIS. 1️⃣5️⃣ The most important stroke period may be after discharge. One of the strongest themes throughout the issue. Etiology completion. Medication adherence. Rehabilitation intensity. Mood. Cognition. Caregiver burden. Stroke care fails surprisingly often during the transition home. The field is moving away from a "recanalization-only" mindset. Modern stroke neurology is becoming: Mechanism-driven. Risk-driven. Recovery-driven. Brain-health-driven. And that is probably the most important update of all. Source: Continuum: Cerebrovascular Disease, June 2026 (AAN). #Stroke #Neurology #VascularNeurology #NeurocriticalCare #StrokePrevention #Neurotwitter #MedX